PetVivo (NASDAQ:PETV – Get Free Report) is projected to release its resultson Monday, August 10th. Analysts expect the company to announce earnings of ($0.08) per share and revenue of $0.0050 million for the quarter.
PetVivo Trading Down 4.4%
NASDAQ PETV opened at $0.65 on Friday. The business’s fifty day moving average is $0.76 and its 200-day moving average is $0.78. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.42 and a quick ratio of 0.47. The stock has a market capitalization of $24.67 million, a price-to-earnings ratio of -1.44 and a beta of 1.27. PetVivo has a one year low of $0.60 and a one year high of $1.69.
PetVivo Company Profile
PetVivo, Inc, headquartered in Ormond Beach, Florida, is a regenerative biomedical technology company specializing in veterinary applications. The company’s core focus is on developing and commercializing sustained-release intra-articular therapies for animals through its proprietary RediVet injectable micro-plug system. This biodegradable polymer platform is designed to provide controlled release of therapeutic agents directly into joints, targeting osteoarthritis and related inflammatory conditions in companion and performance animals.
PetVivo’s lead product, the RediVet-40 system, has been evaluated in proof-of-concept trials involving canine patients with osteoarthritis.
Featured Stories
- Five stocks we like better than PetVivo
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Receive News & Ratings for PetVivo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetVivo and related companies with MarketBeat.com's FREE daily email newsletter.
